Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alendronate therapy in men with primary hyperparathyroidism.

Khan AA, Bilezikian JP, Kung A, Dubois SJ, Standish TI, Syed ZA. Alendronate therapy in men with primary hyperparathyroidism. Endocr Pract. 2009 Nov-Dec; 15(7):705-13.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.